Department of Internal Medicine, Section of Nephrology, Yale School of Medicine, New Haven, Connecticut.
Department of Genetics, Yale School of Medicine, New Haven, Connecticut.
Kidney360. 2020 Oct;1(10):1068-1076. doi: 10.34067/kid.0002522020.
A major difference between autosomal recessive polycystic kidney disease (ARPKD) and autosomal dominant polycystic kidney disease (ADPKD) lies in the pattern of inheritance, and the resultant timing and focality of cyst formation. In both diseases, cysts form in the kidney and liver as a consequence of the cellular recessive genotype of the respective disease gene, but this occurs by germline inheritance in ARPKD and somatic second hit mutations to the one normal allele in ADPKD. The fibrocystic liver phenotype in ARPKD is attributed to abnormal ductal plate formation because of the absence of expression during embryogenesis and organ development. The finding of polycystic liver disease in a subset of adult heterozygous carriers raises the question of whether somatic second hit mutations in in adults may also result in bile duct-derived cyst formation.
We used an adult-inducible mouse model to examine whether has a functional role in maintaining bile duct homeostasis after normal liver development.
Inactivation of beginning at 4 weeks of age resulted in a polycystic liver phenotype with minimal fibrosis at 17 weeks. Increased biliary epithelium, which lines these liver cysts, was most pronounced in female mice. We assessed genetic interaction of this phenotype with either reduced or increased copies of , and found no significant effects on the phenotype in the liver or kidney from altered expression.
Somatic adult inactivation of results in a polycystic liver phenotype. is a required gene in adulthood for biliary structural homeostasis independent of . This suggests that heterozygous carrier patients can develop liver cysts after somatic mutations in their normal copy of .
常染色体隐性多囊肾病(ARPKD)和常染色体显性多囊肾病(ADPKD)之间的一个主要区别在于遗传模式,以及由此导致的囊肿形成的时间和部位。在这两种疾病中,由于各自疾病基因的细胞隐性基因型,囊肿在肾脏和肝脏中形成,但在 ARPKD 中,这是通过种系遗传发生的,而在 ADPKD 中,正常等位基因的体细胞二次打击突变。ARPKD 的纤维囊性肝病表型归因于导管板形成异常,因为在胚胎发生和器官发育过程中 表达缺失。在一部分成年杂合子携带者中发现多囊肝病,这引发了一个问题,即在成年期 中的体细胞二次打击突变是否也可能导致胆管源性囊肿形成。
我们使用成年诱导型 小鼠模型来研究 在正常肝脏发育后维持胆管稳态是否具有功能作用。
从 4 周龄开始失活 导致多囊肝病,17 周时纤维化程度最小。这些肝囊肿内的增生胆管上皮最为明显,在雌性小鼠中更为明显。我们评估了这种表型与 减少或增加拷贝数的遗传相互作用,发现改变 表达对肝脏或肾脏中的 表型没有显著影响。
成年期 体细胞失活导致多囊肝病。 在成年期是维持胆管结构稳态所必需的基因,与 无关。这表明,在其正常拷贝的 中发生体细胞突变后,杂合子携带者患者可以发展为肝囊肿。